- 1Center for Proteomics and Metabolomics, State Key Laboratory of Bio-Control, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), School of Life Sciences, Sun Yat-sen University, Guangzhou, China
- 2Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China
- 3Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Department of Biotechnology, College of Life Science and Technology, Jinan University, Guangzhou, China
Vaccines are safe and efficient in controlling bacterial diseases in the aquaculture industry and are in line with green farming. The present study develops a previously unreported approach to prepare a live-attenuated V. alginolyticus vaccine by culturing bacteria in a high concentration of magnesium to attenuate bacterial virulence. Furthermore, metabolomes of zebrafish immunized with the live-attenuated vaccines were compared with those of survival and dying zebrafish infected by V. alginolyticus. The enhanced TCA cycle and increased fumarate were identified as the most key metabolic pathways and the crucial biomarker of vaccine-mediated and survival fish, respectively. Exogenous fumarate promoted expression of il1β, il8, il21, nf-κb, and lysozyme in a dose-dependent manner. Among the five innate immune genes, the elevated il1β, il8, and lysozyme are overlapped in the vaccine-immunized zebrafish and the survival from the infection. These findings highlight a way in development of vaccines and exploration of the underlying mechanisms.
Introduction
Aquaculture contributes significantly to mankind, not only providing huge amounts of high-quality food, but also promoting human economic development. However, the rapid intensification of aquaculture has adverse ramifications, such as disease outbreaks, which are a major impediment to the growth of aquaculture (1, 2). Vibrio alginolyticus is an important pathogen to both aquatic animals and humans. In aquaculture, it infects a variety of aquatic animals, such as orange-spotted grouper (3), large yellow croaker (4), and white shrimp (5, 6), leading to massive mortality of farmed fishes and thereby causing serious damage to aquaculture. In humans, it causes sepsis, gastroenteritis, wound, and ear infections. Antibiotics are effective to control infection caused by the bacterium, but the misuse and abuse of antibiotics negatively impacts on aquatic environments, food safety, and development of antibiotic resistance (7, 8). Therefore, an alternative approach is especially needed.
Vaccines, taking advantages of reducing dependence on antibiotics, are known to be used to provide long-lasting protection against diseases and thus improve fish health and reduce disease outbreaks with no drug residues. Several types of vaccines have already been developed, such as inactivated whole-cell (9, 10), live attenuated vaccines (9, 11–13), protein subunits (14, 15), anti-idiotypic (16), and DNA vaccines (17, 18). To date, most commercially available and authorized vaccines used in the aquaculture industry are the inactivated whole-cell vaccines, whereas the development of live-attenuated and combined vaccines is in a demanding process (19). Comparatively, the inactivated whole-cell vaccines usually provide poor but stable immunity, while live attenuated vaccines have higher protective efficacy and they do not require adjuvants that only require single or few injections to provide protection. In Europe, a licensed live-attenuated vaccine against V. vulnificus protecting eels from vibriosis has been issued in clinic (20), suggesting live-attenuated vaccine is an effective approach to control infection caused by Vibrio spp. However, the development of vaccines is still limited in aquaculture due to the large reservoir of bacterial pathogens in the ecosystem that can hardly be protected by a single type of vaccine and the various types of species of aquatic animals. Thus, a novel vaccine-developing strategy is urgently needed.
Live-attenuated vaccines are developed in several ways. Random mutation(s) were generated through successive passage of virulent strains under specific conditions (21–23) or transposon based random insertion mutations or allelic exchange have been frequently adopted (24, 25). Among the targeted genes, genes encoding metabolic enzymes are selected for vaccine candidates. The mutation of isocitrate dehydrogenase (icd) gene in Vibrio anguillarum attenuate bacterial virulence and subsequently protected rainbow trout (Oncorhynchus mykiss) against infection caused by the bacterium (26). Tricarboxylic acid (TCA) cycle must operate as a complete cycle for Salmonella enterica serovar Typhimurium SR-11 to be fully virulent but loss of different genes of the TCA cycle causes a different level of loss of virulence (27, 28). Specifically, SR-11 ΔsucAB mutant, which is unable to convert α-ketoglutarate to succinyl-coenzyme A (CoA), is avirulent; SR-11 ΔsucCD mutant, unable to generate succinate from succinyl-CoA, is moderately attenuated; SR-11 ΔsdhCDA mutant, unable to generate fumarate from succinate, is slightly attenuated; and SR-11 Δmdh mutant, unable to convert malate to oxaloacetate, is highly attenuated (27, 28). Thus, altering enzymatic activity may represent an efficient approach to develop live-attenuated vaccines.
Mg2+ participates in a multitude of essential processes. The majority of cytosolic Mg2+ is involved in various aspects of protein synthesis such as being a cofactor, a counter ion for ATP or neutralizing negative charges from phosphates present in the rRNA and then assemble ribosomes (29, 30). Without sufficient Mg2+, ribosomal subunits fall apart and membranes become leaky (31). Free ionic Mg2+ regulates many important metabolic enzymes and membrane channels at specific metal binding sites. At concentrations naturally present in seawater, Mg2+ improves migration without altering the growth rate of Vibrio fischeri. Mg2+ addition enhances flagellation, at least in part through an effect on the steady-state levels of flagellin protein (32). The presence of magnesium is a critical factor in promoting type III secretion system of protein substrates in V. parahaemolyticus (33). V. alginolyticus is a mildly halophilic bacterium which is considered to be V. parahaemolyticus type II that can live in seawater with a wide range of magnesium concentrations. Usually, sea water with a salinity of 3.5% contains 54 mM Mg2+ (34). However, clinical and nonclinical V. parahaemolyticus isolates are resistant to 300 mM Mg2+, a concentration that is toxic to many other microorganisms, but bacterial survival is affected (35), suggesting that the high magnesium concentration is a strong stress to these bacteria. Thus, we hypothesized that V. alginolyticus cultured in high magnesium concentrations may be a new approach to develop live-attenuated vaccines.
Materials and Methods
Bacterial Strain and Culture Conditions
V. alginolyticus ATCC33787 was purchased from the Guangdong Province Microbial Culture Collection (GDMCC). V. alginolyticus is grown in 3% NaCl 0.5% yeast overnight and 1:100 using fresh 3% NaCl 0.5% yeast medium and grown at 30°C. For growth curve, OD600 of the bacterial cultures was measured in medium with 0, 0.78, 3.125, 12.5, 50 or 200 mM MgCl2, which were designed according to the event that 50 mM is approximately the MgCl2 concentration of coastal waters and then 50 time or divided by 4 for other concentrations. Notably, different from V12G01 used in a previous report (36), which caused infectious symptoms to significantly appear after 40 h, ATCC33787 led to the similar infectious symptoms after 24 h.
Swarming and Swimming
V. alginolyticus was inoculated into 5 ml of 3% NaCl and 0.5% yeast medium and cultured at 30°C overnight. Then 10 μl of each sample was spotted onto the center of 1.5% or 0.3% agar LB plates with 3% NaCl and 0, 0.78, 3.125, 12.5, 50 or 200 mM MgCl2 for swarming and swimming, respectively. These plated samples were incubated in a constant temperature incubator at 30°C for 8 h for the diameter of the halo.
Fish
Zebrafish (~0.2g body weight), Danio rerio, were obtained from a zebrafish breeding corporation (Guangzhou, China). Zebrafish were reared in 25 L water tanks and each tank was equipped with closed recirculating aquaculture systems. These fish were cultured for two weeks before experimental manipulation and were fed twice daily.
Bacterial Challenge and Sample Preparation for GC–MS Analysis
For the metabolic profile of zebrafish injected by vaccine, zebrafish (n = 180) were randomly divided into two groups, control group (n = 90) and bacterial vaccination group (n = 90). The control group was injected with 5 μl of 3% saline per fish and the vaccination group was intramuscularly injected with 5 μl V. alginolyticus cultured with 200 mM MgCl2 (2 × 105 CFU) per fish. Spleens were collected at 48 h post-injection. Nine spleens were mixed for a sample. A total of ten samples were obtained for GC–MS analysis.
For the metabolic profile of survival and dying zebrafish from bacterial infection, zebrafish (n = 270) were randomly divided into two groups, control group (n = 90) and bacterial challenge group (n = 180). The control and bacterial challenge groups were intramuscularly injected with 5 μl of 3% saline and 5 μl V. alginolyticus (8 × 105 CFU, half lethal dose) per fish, respectively. Spleens were collected at 24 h post-injection. Nine spleens were mixed for a sample. A total of ten samples were obtained for GC–MS analysis.
To prepare the fish sample for the GC–MS analysis, samples were quenched with 1 ml of cold methanol (HPLC, Sigma Aldrich) and sonicated for 5 min at a 200 W power setting. After centrifugation at 12,000g for 10 min, 10 μl of 0.1 mg/ml ribitol (Sigma Aldrich) as an analytical internal standard was added. The supernatant was concentrated for 4 h in a rotary vacuum centrifuge device, LABCONCO. The dried polar extracts were used for the GC–MS analysis. Ten biological samples with two technical repeats were separately used for the test and control groups.
GC–MS Analysis
GC–MS analysis was carried out with a variation on the two stage techniques as described previously (37, 38). In brief, samples were derivatized through two steps. First, 80 μl of 20 mg/ml methoxamine hydrochloride in pyridine (Sigma) was added to the extracts and incubated for 3 h at 37°C. Then, 80 μl N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA, Sigma-Aldrich) was put and incubated for 1.5 h at 37°C. The samples were centrifuged at 12,000g for 10 min at 4°C. A sample analysis was carried out by Agilent 7890A GC equipped with an Agilent 5975C VL MSD detector (Agilent Technologies, Santa Clara, CA, USA). The injector temperature was kept at 270°C, and 0.1 μl aliquot was injected into a column. Temperature program of the GC oven was held at 85°C for 5 min, followed by an increase to 270°C at a rate of 15°C min and then held for 5 min. Helium was used as carrier gas and its flow rate was 1 ml/min. The MS was operated in a range of 50–600 m/z. For each sample, two technical replicates were prepared to confirm the reproducibility of the reported procedures.
Exogenous Administration of Sodium Malonate and Bacterial Challenge
To investigate the effect of the TCA cycle on host survival, a total of 80 zebrafish were randomly divided into saline group (n = 20) and sodium malonate group (n = 60). For sodium malonate group, the fish were further randomly divided into three subgroups (n = 20). Each subgroup was reared in an individual tank. Control group was injected with 5 μl saline (0.85% sodium chloride) per fish, while the three subgroups were separately injected with 12.5, 25, and 50 mM sodium malonate, once per day for three days via intraperitoneal injection. These fish were intramuscularly challenged with 5 μl V. alginolyticus (8 × 105 CFU, half lethal dose) per fish.
Measurement of PDH, a-KGDH, SDH, and MDH Activity
The activity of pyruvate dehydrogenase (PDH), a-ketoglutarate dehydrogenase (a-KGDH), succinate dehydrogenase (SDH) and malate dehydrogenase (MDH) was measured as previously reported with a modification (39). Briefly, visceral organs from three zebrafish were pooled and homogenized in ice-cold PBS (pH 7.4) which were added at a ratio of 1:15 (w/v). The homogenates were centrifuged and protein concentration in supernatant was measured by a BCA Protein Assay Kit (Beyotime, China). The reaction buffer for PDH and a-KGDH included 0.5 mM MTT, 2.5 mM MgCl2, 6.5 mM PMS, 0.2 mM TPP, 50 mM PBS, and 2 mM sodium pyruvate (for PDH) or 2 mM sodium α-Ketoglutaric acid (for α-KGDH). The reaction systems of SDH and MDH included 0.5 mM MTT, 13 mM PMS, 50 mM PBS, 5 mM succinate (for SDH) or 50 mM malate (for MDH). All the reactions were performed in a final volume of 200 μl in a 96-well plate. Subsequently, the plate was incubated at 30°C for 10 min for PDH, a-KGDH, SDH, and MDH. The optical absorbance was performed in a microplate reader (Bio-Tek Synergy2, USA) at 566 nm.
Gene Expression by Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
For expression of genes encoding the TCA cycle, zebrafish (n = 252) were divided into five groups, control group (n = 24), vaccination group (n = 24), L group (n = 24), M group (n = 60), and H group (n = 120). Control and vaccination groups were intramuscularly injected with 5 μl saline solution and 5 μl V. alginolyticus cultured with 200 mM MgCl2 (2 × 105 CFU), respectively, each fish. L group, M group, and H group were intramuscularly injected with 5 μl V. alginolyticus (2 × 105 CFU, 8 × 105 CFU, 1.5 × 106 CFU, respectively) each fish. These zebrafish were collected at 24 h post-injection. For expression of genes encoding innate immune immunity, zebrafish were intramuscularly injected with 5 μl (50 or 100 μg) fumaric acid, once a day for three days, and collected from vaccination and bacterial challenge as described earlier. Expression of these genes was analyzed by the qRT-PCR as previously described (39). The total RNA was isolated from spleens pooled from six D. rerio with Trizol (Invitrogen, USA). qRT-PCR was performed in 384-well plates with a total volume of 10 μl containing 5 μl 2 × SYBR Premix Ex TaqTM, 4.6 μl H2O, 0.1 μl cDNA template and 0.2 μl each of forward and reverse primers (10 mM). The reaction mixtures were run on a LightCycler 480 system (Roche, Germany). Data were shown as the relative mRNA expression compared with the β-actin gene by 2−ΔΔCT method. All qRT-PCR reactions were performed for four biological replicates. Gene-specific primers used for qRT-PCR are shown in Table 1.
Results
MgCl2 Influences Phenotype of V. alginolyticus
To investigate the effect of magnesium ion on physiology of V. alginolyticus, growth curve of V. alginolyticus ATCC33787 was determined in a gradient concentration of MgCl2. Different growth rate of the bacterium was observed in different MgCl2 concentrations, especially during the first 1–2 h. The growth rate of ATCC33787 from the fastest to the slowest were in 50 mM ≥ 12.5 mM > 3.125 mM > 0.78 mM > 0 mM > 200 mM MgCl2 (Figure 1A). Furthermore, swarming and swimming experiments were also carried out in the gradient concentration of MgCl2. The strongest swarming was measured in plates with 0.78 mM MgCl2 and then reduced with the increasing MgCl2 (Figure 1B). Interestingly, the swarming ability was lower in plate with 200 mM MgCl2 than without MgCl2 (Figure 1B). However, MgCl2 concentration did not affect swimming ability in plates with 0.78–50 mM MgCl2 and without MgCl2, where the bacterium diffused to all the plates but not evenly distributed in 50 mM MgCl2. When the concentration of MgCl2 reached 200 mM, the distribution was depressed (Figure 1B). Importantly, virulence of ATCC33787 to zebrafish was reduced with the increasing MgCl2 concentrations, where similar survival was detected in zebrafish infected by bacteria cultured in 200 mM MgCl2 and saline control (Figure 1C). When zebrafish were infected with different numbers of 200 mM MgCl2-cultured bacteria, percent survival of zebrafish was elevated with the decreasing numbers of bacteria. Among them, all animals were survived at the infection dose of 2 × 105 CFU bacteria (Figure 1D). Furthermore, zebrafish were immunized with 2 × 105 CFU of 200 mM MgCl2-cultured bacteria or saline. Then, zebrafish were challenged with a lethal dose of 5 × 106 CFU V. alginolyticus ATCC33787. When all animals died in the control group, 76% animals survived in the experiment group (Figure 1E). These results indicate that 200 mM MgCl2-cultured ATCC33787 can be used as a live-attenuated vaccine candidate against infection caused by V. alginolyticus.
Figure 1 MgCl2 regulates ATCC33787 phenotypes. (A) Growth curve of ATCC33787 cultured in medium with 0, 0.78, 3.125, 12.5, 50, and 200 mM MgCl2.(B) Swimming and swarming of ATCC33787 cultured in medium with 0, 0.78, 3.125, 12.5, 50, and 200 mM MgCl2. (C) Percent survival of zebrafish infected by V. alginolyticus cultured in medium with different concentrations of MgCl2. (D) Percent survival of zebrafish infected by different amounts of V. alginolyticus cultured in 200 mM MgCl2. (E) Percent survival of zebrafish immunized by V. alginolyticus cultured in 200 mM MgCl2 and challenged by V. alginolyticus. Results (A) are displayed as mean ± SEM, and significant differences are identified (*p < 0.05; **p < 0.01) as determined by two-tailed Student’s t-test.
Metabolome of Zebrafish Immunized With the Live-Attenuated Vaccine Candidate
Hosts against bacterial infection have infective and anti-infective metabolomes, which decide the consequences of infection (36, 40). This motivated us to explore the metabolic mechanisms by which the vaccine candidate protects zebrafish against the bacterial infection. To test this idea, GC–MS based metabolomics was adopted to investigate the metabolic profiles of control group (injected with saline) and vaccination group (injected with 2 × 105 CFU of the V. alginolyticus vaccine). Nine spleens were pooled as one sample. A total of 240 aligned peaks were identified in each sample. After the removal of internal standard, ribitol, any known artificial peaks, and merge of the same compounds, 80 metabolites with reliable signals were identified in each sample. Ten samples with two technical repeats for each sample were included in each group, yielding 40 data sets. The correlation coefficient between technical replicates varied between 0.996 and 0.999, demonstrating the reproducibility of the data (Supplementary Figure 1A). According to the Kyoto Encyclopedia of Genes and Genomes (KEGG), 38, 27, 20, 12, and 3% of the metabolites were categorized to carbohydrate, amino acid, fatty acid, nucleotide, and others, respectively (Supplementary Figure 1B). The metabolomic profiles of these two groups were displayed as heat map (Supplementary Figure 1C). Kruskal–Wallis test was used to compare the two groups, where 61 differential abundances of metabolites were identified as shown in Figure 2A. A Z-score plot ranged from −4.9 to 18.1 in the vaccination group compared to control group and showed 15 increased metabolites and 46 decreased metabolites (Figure 2B). Among these differential abundances of metabolites, 37, 34, 17, and 12% of the metabolites were carbohydrate, amino acid, lipid, and nucleotide (Supplementary Figure 2). These differential abundances of metabolites were analyzed and outlined in KEGG (http://www.genome.jp/kegg) and MetPA (http://metpa.metabolomics.ca), respectively, for pathway enrichment. A total of eight metabolic pathways were enriched, where the top three impactful pathways were TCA cycle, pyruvate metabolism, alanine, aspartate and glutamate metabolism (Figure 2C). Interestingly, among the eight enriched pathways, all differential abundances of metabolites were elevated in the TCA cycle and pyruvate metabolism but reduced in valine, leucine, and isoleucine biosynthesis (Figure 2D). Therefore, the TCA cycle can be further explored for vaccine-conferred protection.
Figure 2 Metabolomic analysis of zebrafish to V. alginolyticus cultured in 200 mM magnesium. (A) Heat map showing relative abundance of metabolites (Wilcoxon P <0.05) in control, vaccination groups. Heat map scale (blue to yellow: low to high abundance) is shown at bottom. (B) Z scores map in control, vaccination groups. (C) Enriched metabolic pathways in control, vaccination groups. (D) Change of the abundance of the metabolites. The lists of the 60 metabolites enriched in the eight pathways in panel (C). Yellow indicates increase; Blue indicates decrease.
Metabolome of Zebrafish Infected With LD50 of ATCC33787
To understand differential metabolic profiles between survival and dead zebrafish infected with V. alginolyticus, GC–MS was used to characterize the metabolomes of survival and dying zebrafish infected with LD50 of ATCC33787 and saline group. GC–MS was performed as described above. The identified 72 metabolites (p <0.05) in survival and dying groups were shown as heatmap, where survival and control groups were clustered (Figure 3A). The differential abundances of metabolites were identified between the control and survival groups or control and dying groups by Kruskal–Wallis test. Approximately 59 metabolites and 64 metabolites were identified (p <0.05) in survival metabolome and dying metabolome, respectively. Z scores value of these differential metabolites showed that fumaric acid was the most upregulated metabolite in the survival group, and malic acid was the most downregulated substance in the death group (Figures 3B,C). Pathway analysis of 59 differential metabolites in survival group and 64 differential metabolites in dying group were performed in MetPA, fourteen and thirteen pathways were enriched, respectively, as shown in Figures 3D, E. Interestingly, all metabolites of the TCA cycle and glycine, serine and threonine metabolism were elevated (Figure 3F). These results indicate that the elevated TCA cycle and glycine, serine and threonine metabolism are required for the survival.
Figure 3 Enriched pathways between dying and survival groups. (A) Heat map showing relative abundance of metabolites in control, survival and dying groups. Heat map scale (blue to yellow: low to high abundance) is shown at bottom. (B) Z scores map in control and survival groups. (C) Z scores map in control and dying groups. (D) Enriched metabolic pathways in control and survival groups. (E) Enriched metabolic pathways in control and dying groups. (F) Change of the abundance of the metabolites. Yellow indicates increase, Blue indicates decrease.
Shared Metabolic Modulation Between the Vaccination and Infection
It is interesting to compare the metabolomes induced by the vaccine and mediated by the infection. To do this, a Venn diagram was used to exhibit overlapped and unique metabolites among 61, 59, and 64 differential abundances of metabolites of the vaccination group, survival group, and dying group, respectively. Forty metabolites were shared among these three groups; 6, 10, and 10 were overlapped between the survival and vaccination groups, survival and dying groups, vaccination and dying groups, respectively; 3, 5, and 4 existed only in the survival, vaccination and dying groups, respectively (Figure 4A). Among these 14, 26, and 31 upregulated metabolites of the vaccination, survival and dying groups, respectively, 2 metabolites were shared by the three groups; 7, 10, and 1 metabolites were shared by the survival and vaccination groups, survival and dying groups, vaccination and dying groups, respectively; 7, 4, and 18 metabolites were only present in the survival, vaccination and dying groups, respectively (Figure 4B). Among the 47, 33, and 33 downregulated metabolites of the vaccination, survival and dying groups, respectively, 12 metabolites were shared by the three groups; 10, 9, and 5 were shared by the survival and vaccination group, survival and dying group, vaccination and dying group respectively; 2, 20, and 7 were only present in the survival, vaccination and dying groups, respectively (Figure 4C). When all of the identified metabolites were analyzed together among the three groups, the vaccination and survival groups were clustered (Figure 4D), indicating the survival and vaccination groups have similar metabolic profiles.
Figure 4 Comparative analyses of vaccination group, survival group and dying group. (A) Venn diagram of the total differential metabolites between the vaccination group, the survival group and the dying group. (B) Venn diagram of the upregulated differential metabolites between the vaccination group, the survival group and the dying group. (C) Venn diagram of the downregulated differential metabolites between the vaccination group, the survival group and the dying group. (D) Clusters of global substances’ relative changes between vaccination group, survival group and dying group. (E) Scores plot and S-plot of OPLS-DA model between control, vaccination group in data (Figure 2A). Red triangles highlight candidate biomarkers. (F) Scores plot and S-plot of OPLS-DA model between control and survival group in data (Figure 3A). Red triangles highlight candidate biomarkers. (G) Scores plot and S-plot of OPLS-DA model between control and dying group in data (Figures 2A and 3A). Red triangles highlight candidate biomarkers. (H) Scores plot and S-plot of OPLS-DA model between vaccination, survival and dying group in data. Red triangles highlight candidate biomarkers.
Moreover, orthogonal partial least squares discriminant analysis (OPLS-DA) was adopted to identify shared biomarkers between vaccination and survival groups. To do this, S-plot was used for identification of discriminatory variables. Cut-off values were set as greater or equal to 0.5 and 0.05 absolute value of covariance t and correlation p (corr), respectively. As compared to the control group, seven metabolites were increased and eight metabolites were decreased in the vaccination group (Figure 4E). Whereas five metabolites were increased and 10 metabolites were decreased in the survival group (Figure 4F), while eight metabolites were increased and 10 metabolites were decreased in the dying group (Figure 4G). Among the shared metabolites, the abundance of maltose, glucose, taurine was upregulated and the abundance of glycolic acid, myo-inositol, stearic acid, palmitic acid was downregulated in both of the survival and vaccination groups. Malic acid, an intermediate metabolite of the TCA cycle, was increased in the survival group and decreased in the dying group (Figures 4E–G). PCA analysis among the survival group, dying group and vaccination group further confirms this conclusion. Compared to the dying group, pentadecanoic acid, malic acid, cystathionine, ethanimidoate, glucose, mandelic acid, maltose, galactose, benzoic acid and glutamic acid were increased; myo-inositol, threonine, threonic acid, thymine, threose, palmitelaidic acid, leucine, serine, uridine, heneicosanoic acid, 1-monolinoleoyllglycerol, 4-hydroxybutyric acid, valine, creatinine, heptadecanoic acid, maleic acid, cytosine, stearic acid, palmitic acid, glycolic acid and beta-lactic acid were decreased in the survival and vaccination groups (Figure 4H). These results indicate that the metabolic flux of glycolysis to the TCA cycle instead of fatty acid biosynthesis is shared by the vaccination and survival groups.
Elevation of the TCA Cycle Is Required for Vaccine Efficacy and Survival From Infection
The above results suggest that the TCA cycle plays a crucial role in the protection against bacterial infection. To confirm this, the activity of pyruvate dehydrogenase (PDH), α-Ketoglutarate dehydrogenase (KGDH), succinate dehydrogenase (SDH) and malate dehydrogenase (MDH) in the TCA cycle and pyruvate metabolism were measured. The activity of all enzymes was elevated in the vaccination group, survival group and reduced in the dying group (Figure 5A). Then, iPath was used to compare metabolic pathways among the vaccination, survival and dying groups. The resulting global overview map provided a better insight into the effects of vaccination and infection consequence on the metabolism of the fish, where yellow and blue lines represented increased and decreased pathways in the reprogramming group, respectively. Elevation of the TCA cycle in the vaccination and survival groups and fluctuation of the TCA cycle in dying group form the most characteristic feature (Figures 5B–D). Furthermore, qRT-PCR was used to detect expression of genes encoding the TCA cycle of zebrafish challenged by high (1.5 × 106 CFU, H), middle (8 × 105 CFU, M) and low (2 × 105 CFU, L) doses of ATCC33787 and the 200 mM MgCl2-prepared live-attenuated vaccine (vaccination) and saline solution was used control. They caused 15% survival (survival-H) and 85% dying (dying-H), 60% survival (survival-M) and 40% dying (dying-M), 100% survival (survival-L), and 100% survival (vaccination), respectively. On the whole, higher expression of genes was detected in the three survival groups and vaccination group than the control, while lower expression of genes was measured in the two dying groups than the control. The high expression was ranked as survival-H > survival-M and vaccination > survival-L and low expression was listed as dying-H > dying-M (Figure 5E). Finally, sodium malonate, an inhibitor of SDH, decreased the survival of zebrafish infected with ATCC33787 in a dose-dependent manner (Figure 5F). These results indicate that elevation of the TCA cycle is required for the survival of zebrafish infected with ATCC33787. Consistently, the elevated TCA cycle is a possible reason why the live-attenuated vaccine provides an effective ability against the infection by the bacterium.
Figure 5 iPath analysis and activity of enzymes in dying and survival groups. (A) Enzyme activity of TCA cycle. (B) iPath analysis of the metabolites of differential abundance in the survival group. (C) iPath analysis of the metabolites of differential abundance in the vaccination group. (D) iPath analysis of the metabolites of differential abundance in the dying group. (E) qRT-PCR for expression of genes encoding the TCA cycle of zebrafish challenged by high (1.5 × 106 CFU, H), middle (8 × 105 CFU, M) and low (2 × 105 CFU, L) doses of ATCC33787 and the 200 mM MgCl2-prepared live-attenuated vaccine (vaccination) and saline solution was used control. (F) Percentage of survival of D. rerio when TCA cycle was blocked by inhibitor. Results (A, E) are displayed as mean ± SEM, and significant differences are identified (*p < 0.05; **p < 0.01) as determined by two-tailed Student’s t-test.
Vaccine Enhances Innate Immune Response
Innate immune response contributes to host immune protection against bacterial infection (41, 42). Therefore, it is required to investigate whether the live-attenuated vaccine activates an innate immune response. The expression of ten innate immune genes il1β, il4, il8, il21, tnf-α, c3b, tlr1, tlr3, nf-κb, and lysozyme were measured. Compared to the saline control, the vaccination group exhibited elevated expression of il1β, il8, and lysozyme but the rest of the genes remain unaffected (Figure 6A). Meanwhile, expression of these genes was compared between the survival group and the dying group. The expression of il1β, il8, il21, tnf-α, tlr1, nf-κb, and lysozyme was elevated in the survival group, while the expression of il1β, il4, tlr1, tlr3, and nf-κb was reduced in the dying group (Figure 6B). Importantly, the elevated il1β, il8, and lysozyme were shared between the vaccination and survival groups, where expression of il1β was reduced in the dying group.
Figure 6 Immune response of zebrafish to V. alginolyticus. (A) qRT-PCR for quantifying transcriptional levels of innate immune genes in zebrafish immunized by vaccine. (B) qRT-PCR for quantifying transcriptional levels of innate immune genes in zebrafish of survival and dying groups. (C) qRT-PCR for quantifying transcriptional levels of innate immune genes in zebrafish after injected by fumaric acid. Results are displayed as mean ± SEM, and significant differences are identified (*p < 0.05; **p < 0.01) as determined by two-tailed Student’s t-test.
Recently, we have showed that malic acid of the TCA cycle promotes expression of innate immune genes and thereby improves the survival of zebrafish infected with V. alginolyticus (40). We speculate that the elevated TCA cycle is related to the elevated expression of innate immune genes. To test this, fumaric acid of the TCA cycle was used to test whether it can promote expression of the three shared genes il1β, il8, and lysozyme. Indeed, exogenous fumaric acid increased expression of il1β, il8, and lysozyme in a dose-dependent manner. Besides these, the metabolite also promoted the expression of il21 and nf-κb (Figure 6C). These results indicate that the live-attenuated vaccine improves the immune level of zebrafish by promoting the TCA cycle, and thus elevates the survival rate of zebrafish infected with V. alginolyticus.
Discussion
Reports have indicated that targeting at metabolic enzymes is an efficient way to develop live-attenuated vaccines (26, 27). Mg2+ participates in a multitude of essential processes as a cofactor of enzymes (29, 30). The present study explored the effect of different concentrations of MgCl2 on bacterial virulence to zebrafish, and showed that V. alginolyticus cultured in 200 mM MgCl2 were most potent in reducing virulence, including avirulence to zebrafish and a limited flagellar movement, which is also related to bacterial virulence (43). However, the 200 mM MgCl2-cultured V. alginolyticus still kept immune protection against V. alginolyticus infection and thereby can be used as a live-attenuated vaccine candidate. Furthermore, we explored the mechanisms by which the live-attenuated vaccine protects fish to be free of bacterial infection via metabolic modulation. To do this, comparison among the vaccine-induced metabolome and bacterial infection-mediated survival metabolome and dying metabolome was performed to identify shared characteristic features in metabolism. Pieces of evidence indicated that the activation of the TCA cycle is required for zebrafish to survive from V. alginolyticus infection, where a key metabolite, fumarate, identified from the shared characteristic feature can promote innate immune response. Therefore, the present study develops a previously unreported approach to study mechanisms by which vaccines provide immune protection, which highlights a way in vaccine design and exploration of the underlying mechanisms.
The core finding of the present study is that the live-attenuated vaccine modulates metabolism to regulate innate immune response. Recently, a line of evidence has indicated that there is a close relationship between immune response and metabolism (44–48), but that vaccines activate an innate immune response against bacterial challenge via modulating metabolism is unknown. The enhancement of the TCA cycle forms a characteristic feature when immunized with the live-attenuated vaccine, which is consistent with the elevated and decreased expression of genes encoding the TCA cycle in survival and dying groups, respectively. To validate whether the metabolic modulation is related to immune protection, the present study demonstrated that the enhancement of the TCA cycle is an indicator that indicates vaccine efficacy against infection with V. alginolyticus. On the contrary, the inactivation of the TCA cycle was identified in zebrafish that died of infection. This interesting finding was further confirmed by an inhibitor sodium malonate of the TCA cycle. These results indicate that the activation of the TCA cycle can protect zebrafish against infection caused by V. alginolyticus, which is a mechanism by which the V. alginolyticus cultured in 200 mM MgCl2 provides immune protection. Yang et al. found that boosted TCA cycle enhanced the survival of zebrafish to V. alginolyticus infection, which may be attributed to providing increased immunity against the infection (36, 40). Gong et al. found that the inhibition of pyruvate metabolism and TCA cycle decreased D. reiro survival against V. alginolyticus (43). Therefore, the TCA cycle is key to provide protection against V. alginolyticus infection.
The present study further used fumarate, an intermediate metabolite of the TCA cycle, to explore why the activated TCA cycle can promote immune protection against the infection. In total, four intermediate metabolites of the TCA cycle, namely, fumarate, succinate, malate, and α-ketoglutarate, were detected in the GC–MS analysis. Among them, the abundance of fumarate ranked from high to low: survival from the infection > vaccination > dying from the infection group, which is no different with the control group. Thus, fumarate was selected. Exogenous fumarate promoted the expression of il1β, il8, il21, nf-κb, and lysozyme in a dose-dependent manner. Among the five innate immune genes, the elevated il1β, il8, and lysozyme were overlapped in the vaccine-immunized zebrafish and the survival from the infection. IL-1β and IL-8 are pro-inflammatory cytokines that mediate different kinds of immune responses (44), while lysozyme catalyzes the destruction of the cell walls of certain bacteria (44, 49). They play a key role in the innate immunity against invaded bacterial pathogens. Thus, the activated TCA cycle increased fumarate, thus promoting innate immunity. This finding is consistent with the recent reports that metabolites regulate innate immune response (43, 50, 51).
In summary, the present study develops a previously unreported approach to prepare a live-attenuated V. alginolyticus vaccine by culturing bacteria in a high concentration of magnesium to attenuate bacterial virulence. Furthermore, the mechanisms of the live-attenuated vaccine are explored through understanding metabolic modulation. It is revealed that the live-attenuated vaccine activates the TCA cycle and thereby elevated intermediated metabolites such as fumarate to regulate innate immunity. In our knowledge, this is first report to clarify vaccine-induced mechanisms by metabolic modulation.
Data Availability Statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.
Ethics Statement
The animal study was reviewed and approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University (Approval No. SYSU-IACUC-2020-B126716).
Author Contributions
HL and X-XP conceptualized and designed the project. JY, X-LY and Y-BS performed experiments. JY and HL interpreted the data. HL and X-XP wrote the manuscript. All authors contributed to the article and approved the submitted version.
Funding
This work was sponsored by the Projects of Natural Science Foundation of China for International Cooperation and Exchanges NSFC (32061133007, 31911530183) and the Innovation Group Project of Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai) (311021006).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2021.739591/full#supplementary-material
Supplementary Figure 1 | Metabolomic profiling of vaccinated D. rerio speen. (A) Reproducibility of metabolomic profiling platform. Metabolite abundances quantified in cell samples over two technical replicates are shown. Correlation coefficient between technical replicates varies between 0.991 and 0.999. This plot shows the two replicates with the weakest correlation of 0.991. (B) Categories of the different metabolites. Eighty metabolites with different abundance were searched against in KEGG for their categories. (C) Heat map showing relative abundance of eighty metabolites in control and vaccination groups. Heat map scale (blue to yellow: low to high abundance).
Supplementary Figure 2 | Categories of the 61 differential metabolites.
References
1. Cawthorn DM, Mariani S. Global Trade Statistics Lack Granularity to Inform Traceability and Management of Diverse and High-Value Fishes. Sci Rep (2017) 7:12852. doi: 10.1038/s41598-017-12301-x
2. Sato M, Ishihara M, Furukawa K, Kaneshiro N, Nagai T, Mitani G, et al. Recent Technological Advancements Related to Articular Cartilage Regeneration. Med Biol Eng Comput (2008) 46:735–43. doi: 10.1007/s11517-008-0360-9
3. Cui M, Zhang Q, Yao Z, Zhang Z, Zhang H, Wang Y. Immunoglobulin M Gene Expression Analysis of Orange-Spotted Grouper, Epinephelus Coioides, Following Heat Shock and Vibrio Alginolyticus Challenge. Fish Shellfish Immun (2010) 29:1060–5. doi: 10.1016/j.fsi.2010.08.018
4. Wu J, Shi YH, Zhang XH, Li CH, Li MY, Chen J. Molecular Characterization of an IL-1beta Gene From the Large Yellow Croaker (Larimichthys Crocea) and Its Effect on Fish Defense Against Vibrio Alginolyticus Infection. Zool Res (2015) 36:133–41.
5. Hsu CH, Chen JC, Lin YC, Chen YY, Liu PC, Lin BW, et al. White Shrimp Litopenaeus Vannamei That Have Received Mixtures of Heat-Killed and Formalin-Inactivated Vibrio Alginolyticus and V. Harveyi Exhibit Recall Memory and Show Increased Phagocytosis and Resistance to Vibrio Infection. Fish Shellfish Immun (2020) 112:151–8. doi: 10.1016/j.fsi.2020.11.013
6. Ngo HV, Huang HT, Lee PT, Liao ZH, Chen HY, Nan FH. Effects of Phyllanthus Amarus Extract on Nonspecific Immune Responses, Growth, and Resistance to Vibrio Alginolyticus in White Shrimp Litopenaeus Vannamei. Fish Shellfish Immun (2020) 107:1–8. doi: 10.1016/j.fsi.2020.09.016
7. Oh EG, Son KT, Yu H, Lee TS, Lee HJ, Shin S, et al. Antimicrobial Resistance of Vibrio Parahaemolyticus and Vibrio Alginolyticus Strains Isolated From Farmed Fish in Korea From 2005 Through 2007. J Food Prot (2011) 74:380–6. doi: 10.4315/0362-028X.JFP-10-307
8. Snoussi M, Noumi E, Hajlaoui H, Usai D, Sechi LA, Zanetti S, et al. High Potential of Adhesion to Abiotic and Biotic Materials in Fish Aquaculture Facility by Vibrio Alginolyticus Strains. J Appl Microbiol (2009) 106:1591–9. doi: 10.1111/j.1365-2672.2008.04126.x
9. Adams A. Progress, Challenges and Opportunities in Fish Vaccine Development. Fish Shellfish Immun (2019) 90:210–4. doi: 10.1016/j.fsi.2019.04.066
10. Abu Nor N, Zamri-Saad M, Md Yasin IS, Salleh A, Mustaffa-Kamal F, Matori MF, et al. Efficacy of Whole Cell Inactivated Vibrio Harveyi Vaccine Against Vibriosis in a Marine Red Hybrid Tilapia (Oreochromis Niloticus × O. Mossambicus) Model. Vaccines (Basel) (2020) 8:734. doi: 10.3390/vaccines8040734
11. Ding C, Liu Q, Li J, Ma J, Wang S, Dong Q, et al. Attenuated Listeria Monocytogenes Protecting Zebrafish (Danio Rerio) Against Vibrio Species Challenge. Microb Pathog (2019) 132:38–44. doi: 10.1016/j.micpath.2019.03.040
12. Zhang HP, Chen MY, Xu YX, Xu GY, Chen JR, Wang YM, et al. An Effective Live Attenuated Vaccine Against Aeromonas Veronii Infection in the Loach (Misgurnus Anguillicaudatus). Fish Shellfish Immun (2020) 104:269–78. doi: 10.1016/j.fsi.2020.05.027
13. Zhang D, Gao Y, Li Q, Ke X, Liu Z, Lu M, et al. An Effective Live Attenuated Vaccine Against Streptococcus Agalactiae Infection in Farmed Nile Tilapia (Oreochromis Niloticus). Fish Shellfish Immun (2020) 98:853–9. doi: 10.1016/j.fsi.2019.11.044
14. Zhao Z, Xiong Y, Zhang C, Jia YJ, Qiu DK, Wang GX, et al. Optimization of the Efficacy of a SWCNTs-Based Subunit Vaccine Against Infectious Spleen and Kidney Necros Is Virus in Mandarin Fish. Fish Shellfish Immun (2020) 106:190–6. doi: 10.1016/j.fsi.2020.07.062
15. Li N, Yang Z, Bai J, Fu X, Liu L, Shi C, et al. A Shared Antigen Among Vibrio Species: Outer Membrane Protein-OmpK as a Versatile Vibriosis Vaccine Candidate in Orange-Spotted Grouper (Epinephelus Coioides). Fish Shellfish Immun (2010) 28:952–6. doi: 10.1016/j.fsi.2010.02.010
16. Qin H, Jin X, Huang W, Liu Y. Production of an Anti-Idiotypic Antibody Single Chain Variable Fragment Vaccine Against Edwardsiella Tarda. Acta Biochim Biophys Sin (Shanghai) (2010) 42:129–36. doi: 10.1093/abbs/gmp117
17. Castro R, Martinez-Alonso S, Fischer U, Haro NA, Soto-Lampe V, Wang T, et al. DNA Vaccination Against a Fish Rhabdovirus Promotes an Early Chemokine-Related Recruitment of B Cells to the Muscle. Vaccine (2014) 32:1160–8. doi: 10.1016/j.vaccine.2013.11.062
18. Puente-Marin S, Nombela I, Chico V, Ciordia S, Mena MC, Perez LG, et al. Potential Role of Rainbow Trout Erythrocytes as Mediators in the Immune Response Induced by a DNA Vaccine in Fish. Vaccines (2019) 7:60. doi: 10.3390/vaccines7030060
19. Mohd-Aris A, Muhamad-Sofie MHN, Zamri-Saad M, Daud HM, Ina-Salwany MY. Live Vaccines Against Bacterial Fish Diseases: A Review. Vet World (2019) 12:1806–15. doi: 10.14202/vetworld.2019.1806-1815
20. Collado R, Fouz B, Sanjuan E, Amaro C. Effectiveness of Different Vaccine Formulations Against Vibriosis Caused by Vibrio Vulnificus Serovar E (Biotype 2) in European Eels Anguilla Anguilla. Dis Aquat Organ (2000) 43:91–101. doi: 10.3354/dao043091
21. Li J, Mo Z, Li G, Xiao P, Huang J. Generation and Evaluation of Virulence Attenuated Mutants of Edwardsiella Tarda as Vaccine Candidates to Combat Edwardsiellosis in Flounder (Paralichthys Olivaceus). Fish Shellfish Immun (2015) 43:175–80. doi: 10.1016/j.fsi.2014.12.018
22. Sommerset I, Krossoy B, Biering E, Frost P. Vaccines for Fish in Aquaculture. Expert Rev Vaccines (2005) 4:89–101. doi: 10.1586/14760584.4.1.89
23. Hastein T, Gudding R, Evensen O. Bacterial Vaccines for Fish–an Update of the Current Situation Worldwide. Dev Biol (Basel) (2005) 121:55–74.
24. Wang J, Zou LL, Li AX. Construction of a Streptococcus Iniae Sortase A Mutant and Evaluation of Its Potential as an Attenuated Modified Live Vaccine in Nile Tilapia (Oreochromis Niloticus). Fish Shellfish Immun (2014) 40:392–8. doi: 10.1016/j.fsi.2014.07.028
25. Chen Y, Wu F, Wang Z, Tang J, Cai S, Jian J. Construction and Evaluation of Vibrio Alginolyticus DeltaclpP Mutant, as a Safe Live Attenuated Vibriosis Vaccine. Fish Shellfish Immunol (2020) 98:917–22. doi: 10.1016/j.fsi.2019.11.054
26. Mou X, Spinard EJ, Hillman SL, Nelson DR. Isocitrate Dehydrogenase Mutation in Vibrio Anguillarum Results in Virulence Attenuation and Immunoprotection in Rainbow Trout (Oncorhynchus Mykiss). BMC Microbiol (2017) 17:217. doi: 10.1186/s12866-017-1124-1
27. Tchawa YM, Leatham MP, Allen JH, Laux DC, Conway T, Cohen PS. Role of Gluconeogenesis and the Tricarboxylic Acid Cycle in the Virulence of Salmonella Enterica Serovar Typhimurium in BALB/c Mice. Infect Immun (2006) 74:1130–40. doi: 10.1128/IAI.74.2.1130-1140.2006
28. Mercado-Lubo R, Leatham MP, Conway T, Cohen PS. Salmonella Enterica Serovar Typhimurium Mutants Unable to Convert Malate to Pyruvate and Oxaloacetate Are Avirulent and Immunogenic in BALB/c Mice. Infect Immun (2009) 77:1397–405. doi: 10.1128/IAI.01335-08
29. Pontes MH, Sevostyanova A, Groisman EA. When Too Much ATP Is Bad for Protein Synthesis. J Mol Biol (2015) 427:2586–94. doi: 10.1016/j.jmb.2015.06.021
30. Yamagami R, Huang R, Bevilacqua PC. Cellular Concentrations of Nucleotide Diphosphate-Chelated Magnesium Ions Accelerate Catalysis by RNA and DNA Enzymes. Biochemistry-US (2019) 58:3971–9. doi: 10.1021/acs.biochem.9b00578
31. Hans S, Fatima Z, Hameed S. Magnesium Deprivation Affects Cellular Circuitry Involved in Drug Resistance and Virulence in Candida Albicans. J Glob Antimicrob Resist (2019) 17:263–75. doi: 10.1016/j.jgar.2019.01.011
32. O'Shea TM, Deloney-Marino CR, Shibata S, Aizawa S, Wolfe AJ, Visick KL. Magnesium Promotes Flagellation of Vibrio Fischeri. J Bacteriol (2005) 187:2058–65. doi: 10.1128/JB.187.6.2058-2065.2005
33. Sarty D, Baker NT, Thomson EL, Rafuse C, Ebanks RO, Graham LL, et al. Characterization of the Type III Secretion Associated Low Calcium Response Genes of Vibrio Parahaemolyticus Rimd2210633. Can J Microbiol (2012) 58:1306–15. doi: 10.1139/w2012-109
34. Potis WTW. Osmotic and Ionic Regulation. Annu Rev Physiol (1968) 30:73–104. doi: 10.1146/annurev.ph.30.030168.000445
35. Ju CH, Yeung PS, Oesterling J, Seigerman DA, Boor KJ. Vibrio Parahaemolyticus Growth Under Low-Iron Conditions and Survival Under High-Magnesium Conditions. J Food Prot (2006) 69:1040–5. doi: 10.4315/0362-028x-69.5.1040
36. Yang MJ, Cheng ZX, Jiang M, Zeng ZH, Peng B, Peng XX, et al. Boosted TCA Cycle Enhances Survival of Zebrafish to Vibrio Alginolyticus Infection. Virulence (2018) 9:634–44. doi: 10.1080/21505594.2017.1423188
37. Cheng Z, Guo C, Chen Z, Yang T, Zhang J, Wang J, et al. Glycine, Serine and Threonine Metabolism Confounds Efficacy of Complement-Mediated Killing. Nat Commun (2019) 10:3325. doi: 10.1038/s41467-019-11129-5
38. Yang DX, Yang MJ, Yin Y, Kou TS, Peng LT, Chen ZG, et al. Serine Metabolism Tunes Immune Responses to Promote Oreochromis Niloticus Survival Upon Edwardsiella Tarda Infection. mSystems (2021) 6:e0042621. doi: 10.1128/mSystems.00426-21
39. Yang MJ, Jiang M, Peng XX, Li H. Myo-Inositol Restores Tilapia’s Ability Against Infection by Aeromonas Sobria in Higher Water Temperature. Front Immunol (2021) 12:682724. doi: 10.3389/fimmu.2021.682724
40. Yang MJ, Xu D, Yang DX, Yang DX, Li L, Peng XX, et al. Malate Enhances Survival of Zebrafish Against Vibrio Alginolyticus Infection in the Same Manner as Taurine. Virulence (2020) 11:349–64. doi: 10.1080/21505594.2020.1750123
41. Munschauer M, Vogel J. Nuclear lncRNA Stabilization in the Host Response to Bacterial Infection. EMBO J (2018) 37:e99875. doi: 10.15252/embj.201899875
42. Break TJ, Jun S, Indramohan M, Carr KD, Sieve AN, Dory L, et al. Extracellular Superoxide Dismutase Inhibits Innate Immune Responses and Clearance of an Intracellular Bacterial Infection. J Immunol (2012) 188:3342–50. doi: 10.4049/jimmunol.1102341
43. Wang L, Huang L, Su Y, Qin Y, Kong W, Ma Y, et al. Involvement of the Flagellar Assembly Pathway in Vibrio Alginolyticus Adhesion Under Environmental Stresses. Front Cell Infect Microbiol (2015) 5:59. doi: 10.3389/fcimb.2015.00059
44. Jiang M, Gong QY, Lai SS, Cheng ZX, Chen ZG, Zheng J, et al. Phenylalanine Enhances Innate Immune Response to Clear Ceftazidime-Resistant Vibrio Alginolyticus in Danio Rerio. Fish Shellfish Immun (2019) 84:912–9. doi: 10.1016/j.fsi.2018.10.071
45. Jiang M, Yang LF, Zheng J, Chen ZG, Peng B. Maltose Promotes Crucian Carp Survival Against Aeromonas Sobrial Infection at High Temperature. Virulence (2020) 11:877–88. doi: 10.1080/21505594.2020.1787604
46. Gong QY, Yang MJ, Yang LF, Chen ZG, Jiang M, Peng B. Metabolic Modulation of Redox State Confounds Fish Survival Against Vibrio Alginolyticus Infection. Microb Biotechnol (2020) 13:796–812. doi: 10.1111/1751-7915.13553
47. Jiang M, Yang LF, Chen ZG, Lai SS, Zheng J, Peng B. Exogenous Maltose Enhances Zebrafish Immunity to Levofloxacin-Resistant Vibrio Alginolyticus. Microb Biotechnol (2020) 13:1213–27. doi: 10.1111/1751-7915.13582
48. Jiang M, Chen ZG, Zheng J, Peng B. Metabolites-Enabled Survival of Crucian Carps Infected by Edwardsiella Tarda in High Water Temperature. Front Immunol (2019) 10:1991. doi: 10.3389/fimmu.2019.01991
49. York A. Cellular Microbiology: Lysozyme Protects Bacteria From Beta-Lactams. Nat Rev Microbiol (2018) 16:183. doi: 10.1038/nrmicro.2018.26
50. Xu D, Wang J, Guo C, Peng XX, Li H. Elevated Biosynthesis of Palmitic Acid Is Required for Zebrafish Against Edwardsiella Tarda Infection. Fish Shellfish Immun (2019) 92:508–18. doi: 10.1016/j.fsi.2019.06.041
Keywords: Vibrio alginolyticus, live vaccine, metabolomics, TCA cycle, innate immunity
Citation: Yang J, Yang X-l, Su Y-b, Peng X-x and Li H (2021) Activation of the TCA Cycle to Provide Immune Protection in Zebrafish Immunized by High Magnesium-Prepared Vibrio alginolyticus Vaccine. Front. Immunol. 12:739591. doi: 10.3389/fimmu.2021.739591
Received: 11 July 2021; Accepted: 15 November 2021;
Published: 07 December 2021.
Edited by:
Julia Kzhyshkowska, Heidelberg University, GermanyReviewed by:
Jose Alejandro Chabalgoity, University of the Republic, UruguayGanesh Ram Visweswaran, Seattle Children’s Hospital, United States
Copyright © 2021 Yang, Yang, Su, Peng and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hui Li, lihui32@sysu.edu.cn